Chlamydia trachomatis detection in cervical preserv-cyt specimens from an Irish urban female population

Cytopathology

Volumn 20, Issue 2, 2009, Pages 111-116

  Keegan, H ^a,b   Ryan, F ^b   Malkin, A ^b   Griffin, M ^c,d   Lambkin, H ^b  

^a Pathology Research Laboratory   (Ireland)

^b DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^c St James's Hospital   (United States)

^d TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Cervical cytology; Chlamydia trachomatis; Human papillomavirus; Irish; PreservCyt; Smoking

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM DETECTION; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; DNA EXTRACTION; FEMALE; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SMOKING; UTERINE CERVIX CYTOLOGY; VIRUS INFECTION; WART VIRUS;

ADOLESCENT; ADULT; AGED; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; HUMANS; IRELAND; MASS SCREENING; MIDDLE AGED; SMOKING; URBAN POPULATION; VAGINAL SMEARS; YOUNG ADULT;

EID: 62849099274     PISSN: 09565507     EISSN: 13652303     Source Type: Journal    
DOI: 10.1111/j.1365-2303.2007.00534.x     Document Type: Article

References (39)

1. Brunham RC, Rey-Ladino J. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nat Rev Immunol 2005 5 : 149 61.
2. Polyzos NP, Vittoraki A, Tsappi M et al. Food for thought in women's health. The gynecologist: the new European gatekeeper in Chlamydia trachomatis infection. Acta Obstet Gynecol Scand 2006 85 : 1156 9.
3. Munoz N, Castellsague X, de Gonzalez AB, Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006 24 : S1 10.
4. Berrington de Gonzalez A, Green J. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer 2007 120 : 885 91.
5. Madeleine MM, Anttila T, Schwartz SM et al. Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors. Int J Cancer 2007 120 : 650 5.
6. Smith JS, Bosetti C, Munoz N et al. IARC multicentric case control study. Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentre case-control study. Int J Cancer 2004 111 : 431 9.
7. Health Protection Surveillance Centre. Sexually Transmitted Infections 2004 Annual Summary Report. Dublin, Ireland : HPSC 2005 : pp. 1 18.
8. Health Protection Surveillance Centre. The Need for Chlamydia Screening in Ireland. Dublin, Ireland : HPSC 2005.
9. Centers for Disease Control and Prevention, USA. Recommendations for the prevention and management of Chlamydia trachomatis infections, 1993. MMWR Recomm Rep 1993 42 : 1 39.
10. Centers for Disease Control and Prevention, USA. Sexually Transmitted Diseases Surveillance 2000 Supplement, Chlamydia prevalence monitoring project. Atlanta, GA : US Department of Health and Human Services, Centers for Disease Control and Prevention November 2001.
11. Kamwendo F, Forslin L, Bodin L, Danielsson D. Programmes to reduce pelvic inflammatory disease - the Swedish experience. Lancet 1998 351 : 25 8.
12. Darwin LH, Cullen AP, Crowe SR et al. Evaluation of the hybrid capture 2 CT/GC DNA tests and the GenProbe PACE 2 tests from the same male urethral swab specimen. Sex Transm Infect 2002 29 : 576 80.
13. Lowe P, O'Loughlin P, Evans K et al. Comparison of the Gen-Probe APTIMA Combo 2 assay to the AMPLICOR CT/NG assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine samples from Australian men and women. J Clin Microbiol 2006 44 : 2619 21.
14. Cox T, Cuzick J. HPV DNA testing in cervical cancer screening: from evidence to policies. Gynecol Oncol 2006 103 : 8 11.
15. Lie AK, Risberg B, Borge B et al. DNA- versus RNA-based methods for human papillomavirus detection in cervical neoplasia. Gynecol Oncol 2005 97 : 908 15.
16. Zhang W, Cohenford M, Lentrichia B et al. Detection of Chlamydia trachomatis by isothermal ramification amplification method: a feasibility study. J Clin Microbiol 2002 40 : 128 32.
17. Koumans EH, Black CM, Markowitz LE et al. Comparison of methods for detection of Chlamydia trachomatis and Neisseria gonorrhoeae using commercially available nucleic acid amplification tests and a liquid pap smear medium. J Clin Microbiol 2003 41 : 1507 11.
18. Hopwood J, Mallinson H, Hodgson E, Hull L. Liquid based cytology: examination of its potential in a chlamydia screening programme. Sex Transm Infect 2004 80 : 371 3.
19. Sailors J, Gander R, Saboorian MH et al. Stability of PreservCyt for hybrid capture (HC II) HPV test. Diagn Cytopathol 2005 32 : 260 3.
20. Castle PE, Solomon D, Hildesheim A et al. Stability of archived liquid-based cervical cytologic specimens. Cancer 2003 99 : 89 96.
21. Keegan H, Boland C, Malkin A et al. Comparison of DNA extraction from cervical cells collected in PreservCyt solution for the amplification of Chlamydia trachomatis. Cytopathology 2005 16 : 82 7.
22. Keegan H, Malkin A, Griffin M et al. Validation of a multiplex PCR assay for the simultaneous detection of human papillomavirus and Chlamydia trachomatis in cervical PreservCyt samples. Clin Chem 2005 51 : 1301 2.
23. Wilson JS, Honey E, Templeton A et al. EU Biomed Concerted Action Group. A systematic review of the prevalence of Chlamydia trachomatis among European women. Hum Reprod Update 2002 8 : 385 94.
24. Honey E, Augood C, Templeton A et al. Cost effectiveness of screening for Chlamydia trachomatis: a review of published studies. Sex Transm Infect 2002 78 : 406 12.
25. Powell J, O'Connor C, O'harlaithe M, De Freitas J. Chlamydia trachomatis prevalence in men in the mid-west of Ireland. Sex Transm Infect 2004 80 : 349 53.
26. McMillan HM, O'Carroll H, Lambert JS et al. Screening for Chlamydia trachomatis in asymptomatic women attending outpatient clinics in a large maternity hospital in Dublin, Ireland. Sex Transm Infect 2006 82 : 503 5.
27. Jones S, Barker S, Athan E, Graves S. The tip of the iceberg: opportunistic screening for Chlamydia trachomatis in asymptomatic patients attending a young people's health clinic reveals a high prevalence - a pilot study. Sex Health 2004 1 : 115 9.
28. Mahony J, Chong S, Jang D et al. Urine specimens from pregnant and nonpregnant women inhibitory to amplification of Chlamydia trachomatis nucleic acid by PCR, ligase chain reaction, and transcription-mediated amplification: identification of urinary substances associated with inhibition and removal of inhibitory activity. J Clin Microbiol 1998 36 : 3122 6.
29. Shrier LA, Dean D, Klein E et al. Limitations of screening tests for the detection of Chlamydia trachomatis in asymptomatic adolescent and young adult women. Am J Obstet Gynecol 2004 190 : 654 62.
30. van den Hoek JA, Mulder-Folkerts DK, Coutinho RA et al. Opportunistic screening for genital infections with Chlamydia trachomatis among the sexually active population of Amsterdam. II Over 90% participation and almost 5% prevalence. Ned Tijdschr Geneeskd 1999 143 : 668 72.
31. Adams EJ, Charlett A, Edmunds WJ, Hughes G. Chlamydia trachomatis in the United Kingdom: a systematic review and analysis of prevalence studies. Sex Transm Infect 2004 80 : 354 62.
32. Boardman LA, Stanko C, Weitzen S, Sung CJ. Atypical squamous cells of undetermined significance: human papillomavirus testing in adolescents. Obstet Gynecol Surv 2005 60 : 435 7.
33. Zbroch T, Knapp P, Blonska E et al. Life style, Chlamydia trachomatis infection, bacterial vaginosis and their impact on the frequency of cervical lesions. Ginekol Pol 2004 75 : 538 44.
34. Franceschi S. The IARC commitment to cancer prevention: the example of papillomavirus and cervical cancer. Recent Results Cancer Res 2005 166 : 277 97.
35. Tayal SC, Robertson A, Doxford L. An audit of Chlamydia trachomatis screening in colposcopy - Hartlepool experience. Int J STD AIDS 2005 16 : 500 1.
36. Golijow CD, Abba MC, Mouron SA et al. Chlamydia trachomatis and human papillomavirus infections in cervical disease in Argentine women. Gynecol Oncol 2005 96 : 181 6.
37. Harris DI. Implementation of chlamydia screening in a general practice setting: a 6-month pilot study. J Fam Plann Reprod Health Care 2005 31 : 109 12.
38. Yu MC, Li LH, Tang LH, Chen KT. Genital chlamydial infection among male attendees at a sexually transmitted disease clinic in urban Taiwan. Public Health 2007 121 : 534 9.
39. Marrazzo JM, Ellen JM, Kent C et al. Acceptability of urine-based screening for Chlamydia trachomatis to asymptomatic young men and their providers. Sex Transm Dis 2007 34 : 147 53.